Is ENDRA Life Sciences Inc. (NDRA) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 14.9% / 30% | 82.4% / 30% | 0.0% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 14.9% / 33% | 82.4% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 13.1% / 33% | 72.5% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 14.9% / 33% | 82.4% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 13.1% / 33% | 72.5% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -236.3% | |
| Return on Assets (ROA) | -102.0% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$7M |
| Free Cash Flow | -$7M |
| Total Debt | $584,419 |
| Debt-to-Equity | 306.5 |
| Current Ratio | 1.3 |
| Total Assets | $4M |
Price & Trading
| Last Close | $4.59 |
| 50-Day MA | $3.83 |
| 200-Day MA | $4.88 |
| Avg Volume | 110K |
| Beta | -0.1 |
|
52-Week Range
$2.90
| |
About ENDRA Life Sciences Inc. (NDRA)
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is ENDRA Life Sciences Inc. (NDRA) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), ENDRA Life Sciences Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is ENDRA Life Sciences Inc.'s debt ratio?
ENDRA Life Sciences Inc.'s debt ratio is 14.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 13.1%.
What are ENDRA Life Sciences Inc.'s key financial metrics?
ENDRA Life Sciences Inc. has a market capitalization of $5M, trailing P/E ratio of 0.2. Return on equity stands at -236.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.